<DOC>
<DOCNO>EP-0638572</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Bicyclic derivatives of imidazole, process for their preparation, intermediates; their application as medicaments and pharmaceutical compostions containing them
</INVENTION-TITLE>
<CLASSIFICATIONS>C07C31116	C07D40910	A61P100	A61P912	A61K314164	C07D49506	A61P910	C07D49504	A61P1300	C07D49500	A61P100	C07C31100	A61P908	A61K31435	A61P4300	C07D48700	A61P1500	C07D51300	A61P1500	A61K31415	A61P904	A61K314188	C07D47100	C07D40900	A61P900	C07D23500	A61K314184	C07D40300	A61K3155	A61P1312	C07D51304	A61K31415	C07D47104	A61K31435	C07D48704	A61P900	C07D23524	A61P4300	C07D40310	A61K3155	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07C	C07D	A61P	A61P	A61K	C07D	A61P	C07D	A61P	C07D	A61P	C07C	A61P	A61K	A61P	C07D	A61P	C07D	A61P	A61K	A61P	A61K	C07D	C07D	A61P	C07D	A61K	C07D	A61K	A61P	C07D	A61K	C07D	A61K	C07D	A61P	C07D	A61P	C07D	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07C311	C07D409	A61P1	A61P9	A61K31	C07D495	A61P9	C07D495	A61P13	C07D495	A61P1	C07C311	A61P9	A61K31	A61P43	C07D487	A61P15	C07D513	A61P15	A61K31	A61P9	A61K31	C07D471	C07D409	A61P9	C07D235	A61K31	C07D403	A61K31	A61P13	C07D513	A61K31	C07D471	A61K31	C07D487	A61P9	C07D235	A61P43	C07D403	A61K31	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The subject of the invention is the products of formula (I): 
<
IMAGE
>
  in which:   X1 represents especially alkyl, alkenyl, alkynyl, alkoxy or alkylthio,   n1 represents an integer from 0 to 4, A1, A2, A3 and A4 represent -(CH2)n-, -CH=, -N=, -NH-,  
&
rdurule
&
 C=R3, -S- or -O-, with n representing an integer from 0 to 2, R3 represents an oxygen atom, alkenyl or =N-O-R4 with R4 representing hydrogen, alkyl, alkenyl, acyl or carbamoyl, - R1 and R2 represent especially halogen, carboxyl, acyl, amino, alkyl, alkenyl, alkoxy, alkylthio, phenyl, benzyl or phenoxy, X2 represents especially cyano, carboxyl or -(CH2)n2-SO2-Z-R5 with n2 representing 0 or 1, Z representing -NH-, -NH-CO-, -NH-CO-O-, -N=CH-N-R6, -NH-CO-NH- or a single bond and R5 and R6 representing hydrogen, alkyl, alkenyl or ring, and their salts, their preparation and their application as medicaments.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Products of formula (I):

in which: X
1
 represents a methyl, ethyl, propyl, n-butyl, i-butyl
or terbutyl radical,
A
1
 represents -S-, A
2
 represents -CH
2
,
A
3
 represents -CH
2
- or -CH=, a hydrogen atom being optionally
substituted by a halogen atom, a formyl or free, salified or

esterified carboxy radical,
A
4
 represents 
>
C=O, 
>
C=N-O-CH
2
-COOH, 
>
C=N-OH, 
>
C=CH-COOH,


-CH
2
- with one or both hydrogen atoms
substituted by one or two identical or different radicals

chosen from the amino, hydroxyl and halogen radicals, or -CH=
optionally substituted by an amino, hydroxyl radical or a

halogen atom
X
2
 represents the optionally salified or esterified tetrazolyl 
radical, the -SO
2
-NH-CO-O-R
5
, -SO
2
-NH-CO-R
5
, -SO
2
-N=CH-NR
6
, or
-SO
2
-NH-CO-NH-R
5
 radical in which R
5
 and R
6
 identical or
different, are chosen from the hydrogen atom, the methyl,

ethyl and n-propyl radical,

said products of formula (I) being in all racemic,
enantiomeric and diastereoisomeric isomer forms, as well as

the addition salts with mineral and organic acids or with
mineral and organic bases of said products of formula (I).
The following product

2-butyl 1-[[2'- [[(ethoxycarbonyl] amino]
 sulphonyl] (1,1'-biphenyl)-4-yl]

methyl] 1,5,6,7-tetrahydrothiopyrano [2,3-d]

imidazol 7-carboxylic acid, said products of formula (I),
this product, being in all possible racemic, enantiomeric and

diastereoisomeric isomer forms, as well as the addition salts
with mineral and organic acids or with mineral and organic

bases of said products of formula (I) of this product.
4'-[(2-butyl-7-oxo-1,5,6,7-tetrahydro-thiopyrano[2,3-d]
imidazol-1-yl) methyl]
 N-[(dimethylamino) methylene) (1,1'-biphenyl)
2-sulphonamide,


4'-[(2-butyl-7-oxo-1,5,6,7-tetrahydro-thiopyrano[2,3-d]
imidazol-1-yl) methyl]
 (1,1'-biphenyl) 2-sulphonamide,
ethyl (2-(4'-((2-butyl-1,5,6,7-tetrahydro-7-oxothiopyrano[2,3-d]
imidazol-1-yl) methyl) (1,1'-biphenyl)

sulphonyl) carbamate,
N-(2-(4'-((2-butyl-1,5,6,7-tetrahydro-7-oxothiopyrano[2,3-d]
imidazol-1-yl) methyl) (1,1'-biphenyl)

sulphonyl) N'-propyl-urea,
4'-[(2-butyl-7-(hydroxyimino )-1,5,6,7-tetrahydrothiopyrano[2,3-d]
imidazol-1-yl) methyl]
 (1,1'-biphenyl) 2-sulphonamide,
4'-[(2-butyl-7-((((propylamino) carbonyl) oxy) imino)-1,5,6,7-tetrahydro-thiopyrano[2,3-d]
imidazol-1-yl) methyl]

N-[(propylamino) carbonyl] (1,1'-biphenyl) 2-sulphonamide,
4'-[(2-butyl 7-(hydroxyimino) 1,5,6,7-tetrahydro
thiopyrano[2,3-d]
imidazol-1-yl) methyl] N-((propylamino) 

carbonyl) (1,1'-biphenyl) 2-sulphonamide,
4'-[(2-butyl-1,7-dihydro-7-oxo-thiopyrano[2,3-d]imidazol-1-yl)

methyl] N-[(dimethylamino) methylene) (1,1'-biphenyl)

2-sulphonamide,
4'-[(2-butyl-1,7-dihydro-7-oxo-thiopyrano[2,3-d]imidazol-1-yl)

methyl] (1,1'-biphenyl) 2-sulphonamide,
4'-[(2-butyl-1,7-dihydro-7-oxo-thiopyrano[2,3-d]imidazol-1-yl)

methyl] N-[(propylamino) carbonyl) (1,1'-biphenyl) 2-sulphonamide.
Process for the preparation of the products of formula (I)
as defined in claim 1, 
characterized in that
 a compound of
formula (II):



in which X'
1
, A'
1
, A'
2
, A'
3
 and A'
4
 have the meanings indicated
in claim 1 for X
1
, A
1
, A
2
, A
3
 and A
4
 respectively, in which the
optional reactive functions are optionally protected by

protective groups,

is reacted with a compound of formula (III): 


in which Hal represents a halogen atom, n
1
 represents an
integer from 0 to 4 and X'
2
 has the meaning indicated in claim
1 for X
2
 in which the optional reactive functions are
optionally protected by protective groups,

in order to obtain a product of formula (IV):

 
in which X'
1
, A'
1
, A'
2
, A'
3
, A'
4
, X'
2
 and n
1
 have the meanings
indicated above,

product of formula (IV) already able to constitute a product
of formula (I), if appropriate, is converted in order to

obtain another product of formula (I) or product of formula
(IV) which is converted to a product of formula (I) by

subjecting this product of formula (IV) or this product of
formula (I), if desired and if necessary, to one or more of

the following reactions, in any order:

elimination of the protective groups which can be carried
by the protected reactive functions,
salification by a mineral or organic acid or by a mineral
or organic base in order to obtain the corresponding salt,
esterification of the acid function,
saponification of the ester function to an acid function,
conversion of the alkyloxy function to a hydroxyl function,
conversion of the cyano function to an acid function,
reduction of the carboxy function to an alcohol function,
oxidation of the sulphur atom to sulphoxide or to sulphone,
conversion of the ketone function to an oxime function,
conversion of the ketone function to an alcohol function,
conversion of the amine function to an amide function,
substitution by a halogen atom,
resolving the racemic forms,
said products of formula (I) obtained in this way being in

all possible racemic, enantiomeric and diastereoisomeric
isomer forms.
Process for the preparation of the product of formula (II)
as defined in claim 4, 
characterized in that
 a compound of
formula (Fa): 



in which X
5
 represents an alkyl, alkoxy, hydroxyl, formyl,
alkylthio, phenylthio, benzylthio, free, salified or

esterified carboxy or amino radical, optionally substituted
by one or two alkyl radicals, such that the alkyl and phenyl

radicals of these radicals which can comprise or be
represented by X
5
 are optionally substituted by one or more
radicals chosen from the halogen atoms, the hydroxyl, alkyl,

aralkoxy radicals, and are, if necessary, protected,
is reacted with a lithium or magnesium halide of formula

(Fb) :

A"
2
----
 A"
3
-M Hal

in which Hal represents a halogen atom. M represents a
lithium or magnesium atom and A"
2
 A"
3
 represent either an
ethenyl radical non-substituted or substituted by 1, 2 or 3

R'
1
 and R'
2
 radicals as defined above, in which the optional
reactive functions are optionally protected or one of A"
2
 and
A"
3
 represents an amino radical optionally substituted by one
or two R'
1
 and R'
2
 radicals as defined above, in which the
optional reactive functions are optionally protected above,

in order to obtain a product of formula (Fc):

(Fc): 


in which X'
1
, X
5
, A"
2
 and A"
3
 have the meanings indicated
above, which is oxidized in order to obtain a compound of

formula (Fd):


in which X'
1
, X
5
, A"
2
 and A"
3
 have the meanings indicated
above, which is subjected to a cyclization reaction in order

to obtain the product of formula (Fe):


in which X'
1
, A'
1
, A'
2
 and A'
3
 have the meanings indicated
above, which products of formula (Fe) able constitute a

product of formula (II) which if appropriate is converted in
order to obtain another product of formula (II) or product of

formula (Fe) which is converted to a product of formula (II)
by subjecting it, if desired and if necessary, to one or more

of the following reactions, in any order:

an elimination reaction of the protective groups which can 
be carried by the protected reactive functions,
a salification reaction by a mineral or organic acid or by
a mineral or organic base in order to obtain the

corresponding salt,
an esterification reaction of the acid function,
a saponification reaction of the ester function to an acid
function,
a conversion reaction of the alkyloxy function to a
hydroxyl function,
a conversion reaction of the cyano function to an acid
function,
a conversion reaction of the ketone function to a cyano
function,
a reduction reaction of the carboxy function to an alcohol
function,
a resolution reaction of the racemic forms,
said products of formula (II) obtained in this way being in

all possible racemic, enantiomeric and diastereoisomeric
isomer forms.
As medicaments, the products as defined by formula (I) of
claim 1, said products of formula (I) being in all possible

racemic, enantiomeric and diastereoisomeric isomer forms, as
well as the addition salts with pharmaceutically acceptable

mineral and organic acids or with mineral and organic bases
of said products of formula (I).
The pharmaceutical compositions containing as active
ingredient, at least one of the medicaments as defined in

claim 6.
As new industrial products, the compounds of formula (II).
</CLAIMS>
</TEXT>
</DOC>
